C1orf185: A Potential Drug Target and Biomarker for Chromosome 1 Open Reading Frame 185

Target Name: C1orf185

NCBI ID: G284546

C1orf185

Other Name(s): Chromosome 1 open reading frame 185 | CA185_HUMAN | Uncharacterized protein C1orf185 | chromosome 1 open reading frame 185

C1orf185: A Potential Drug Target and Biomarker for Chromosome 1 Open Reading Frame 185

Chromosome 1 (C1) is one of the chromosomes responsible for carrying the majority of genetic information in the human body. Open Reading Frame (ORF) 185 is a portion of the C1 chromosome that has been identified as a potential drug target and biomarker. In this article, we will discuss the biology of C1orf185, its potential as a drug target, and its potential as a biomarker for various diseases.

Biology of C1orf185

C1orf185 is a 1,851-base pair long ORF located on the C1 chromosome at position 61.8 kb. It is part of the gene that encodes the protein ZNF21, which is a transcription factor that plays a role in regulating gene expression and is associated with various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Potential Drug Target

Several studies have identified C1orf185 as a potential drug target due to its involvement in the regulation of gene expression and its association with various diseases. One of the most significant findings is that C1orf185 is a highly conserved gene that is highly expressed in various tissues, including human placenta, brain, and cancer samples. Additionally, several studies have shown that C1orf185 is involved in the regulation of cellular processes that are associated with cancer, such as cell division, apoptosis, and angiogenesis.

Potential Biomarker

C1orf185 has also been identified as a potential biomarker for various diseases due to its expression in various tissues and its association with cancer. Several studies have shown that C1orf185 is highly expressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, several studies have shown that C1orf185 is involved in the regulation of cellular processes that are associated with cancer progression, such as the regulation of cell proliferation and the inhibition of apoptosis.

Methods

To determine the potential drug target status of C1orf185, several studies have used various techniques, including gene expression arrays, RNA interference, and live cell assays. These studies have shown that C1isf185 is involved in the regulation of gene expression and is highly conserved in various tissues.

In addition to its potential drug target and biomarker properties, C1isf185 is also a good candidate for a potential therapeutic intervention due to its association with various diseases. Studies have shown that C1isf185 is involved in the regulation of cellular processes that are associated with neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Additionally, C1isf185 is also involved in the regulation of cellular processes that are associated with cancer, including the regulation of cell proliferation and the inhibition of apoptosis.

Conclusion

In conclusion, C1isf185 is a portion of the C1 chromosome that has been identified as a potential drug target and biomarker for various diseases. Its conservation in various tissues and its involvement in the regulation of gene expression and cellular processes make it a promising candidate for therapeutic intervention. Further studies are needed to determine its potential as a drug target and biomarker, as well as its potential therapeutic intervention.

Protein Name: Chromosome 1 Open Reading Frame 185

The "C1orf185 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1orf185 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets